Clues to Mapping a Crisis-Ready Tech Transfer Playbook
30 May, 2025
Nassim Farrokhzad, Drug Product Technology Lead at AstraZeneca, weighs in with key lessons learned during the height of the COVID-19 pandemic with Cell & Gene, ahead of her presentation at the 2025 ISPE Biotechnology Conference. Farrokhzad played a pivotal role in AstraZeneca’s rapid response planning during this unprecedented time. She reflects on the company’s tech transfer approach and other key considerations, sharing insights and lessons learned to help the industry improve pandemic readiness.
Learn more about ISPE conferences
About Cell & Gene
Cell & Gene delivers in-depth content about cell and gene therapies from experienced professionals in the field. This publication focuses exclusively on this segment of the life sciences industry.